Table 2

Vascular density values at the 8-month follow-up and other characteristics within groups

Control groupGroup 1: mild diseaseGroup 2: moderate diseaseGroup 3: severe diseaseSignificance among all groups
Superficial central VDMean16.143217.41613.41112.9680.002*
SD3.4054.0794.7933.566
Superficial inferior VDMean50.36850.12552.98050.4640.761*
SD2.7123.3218.2932.483
Superficial superior VDMean49.99549.01350.12850.1410.391
SD2.4062.0532.3762.666
Superficial nasal VDMean43.37342.71644.53044.3400.163
SD2.3023.4962.6942.485
Superficial
temporal VD
Mean47.71146.01549.92548.271<0.001†
SD2.3693.4612.6022.307
Image qualityMean63.4263.4461.95064.1200.452†
SD3.2205.0445.1623.100
FAZ areaMean0.2230.2100.4110.343<0.001†
SD0.1500.0170.0220.026
Deep central VDMean15.49515.78212.43011.3880.002*
SD4.6134.0685.3823.933
Deep inferior VDMean51.50753.22353.32452.6450.7347*
SD5.3273.9743.8093.218
Deep superior VDMean51.06650.99652.46651.3610.484
SD3.6063.1673.4513.175
Deep nasal VDMean49.49746.55150.70749.4190.010†
SD3.6933.0214.4993.650
Deep temporal VDMean48.03448.43050.09247.7080.043*
SD2.8982.8933.0272.769
  • Significant values shown in bold.

  • *H Kruskal-Wallis.

  • †ANOVA test.

  • ANOVA, analysis of variance; FAZ, foveal avascular zone; VD, vessel density.